Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
1.
Behav Genet ; 45(5): 547-59, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26026879

RESUMEN

Feingold syndrome (FS) is an autosomal dominant disorder characterized by microcephaly, short stature, digital anomalies, esophageal/duodenal atresia, facial dysmorphism, and various learning disabilities. Heterozygous deletion of the miR-17-92 cluster is responsible for a subset of FS (Feingold syndrome type 2, FS2), and the developmental abnormalities that characterize this disorder are partially recapitulated in mice that harbor a heterozygous deletion of this cluster (miR-17-92∆/+ mice). Although Feingold patients develop a wide array of learning disabilities, no scientific description of learning/cognitive disabilities, intellectual deficiency, and brain alterations have been described in humans and animal models of FS2. The aim of this study was to draw a behavioral profile, during development and in adulthood, of miR-17-92∆/+ mice, a genetic mouse model of FS2. Moreover, dopamine, norepinephrine and serotonin tissue levels in the medial prefrontal cortex (mpFC), and Hippocampus (Hip) of miR-17-92∆/+ mice were analyzed.Our data showed decreased body growth and reduced vocalization during development. Moreover, selective deficits in spatial ability, social novelty recognition and memory span were evident in adult miR-17-92∆/+ mice compared with healthy controls (WT). Finally, we found altered dopamine as well as serotonin tissue levels, in the mpFC and Hip, respectively, of miR-17-92∆/+ in comparison with WT mice, thus suggesting a possible link between cognitive deficits and altered brain neurotransmission.


Asunto(s)
Encéfalo/fisiopatología , Párpados/anomalías , Discapacidad Intelectual/fisiopatología , Deformidades Congénitas de las Extremidades/fisiopatología , Trastornos Mentales/genética , Microcefalia/fisiopatología , Fístula Traqueoesofágica/fisiopatología , Animales , Conducta Animal/fisiología , Modelos Animales de Enfermedad , Párpados/fisiopatología , Femenino , Discapacidad Intelectual/complicaciones , Discapacidad Intelectual/genética , Deformidades Congénitas de las Extremidades/complicaciones , Deformidades Congénitas de las Extremidades/genética , Masculino , Ratones , Ratones Endogámicos C57BL , MicroARNs/genética , Microcefalia/complicaciones , Microcefalia/genética , Fístula Traqueoesofágica/complicaciones , Fístula Traqueoesofágica/genética
2.
Behav Brain Res ; 229(2): 333-9, 2012 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-22289198

RESUMEN

The impact of stress is widely recognized in the etiology of multiple disorders. In particular, psychological stress may increase the risk of cardiovascular, metabolic, immune, and mood disorders. Several genes are considered potential candidates to account for the deleterious consequences of stress and recent data point to role of Vgf. VGF mRNA is abundantly expressed in the hypothalamus, where it has been involved in metabolism and energy homeostasis; more recently a link between VGF-derived peptides and mood disorders has been highlighted. The following experiments were performed to address the contribution of the VGF-system to stress induced changes in mice: the distribution of VGF immuno-reactivity in hypothalamic nuclei and its modulation by social stress; the role of VGF-derived peptide TLQP-21 in plasma catecholamine release induced by acute restraint stress (RS); the efficacy of chronic TLQP-21 in a mouse model of chronic subordination stress (CSS). VGF fibers were found in high density in arcuate, dorsomedial, and suprachiasmatic and, at lower density, in lateral, paraventricular, and ventromedial hypothalamic nuclei. Central administration of either 2 or 4 mM TLQP-21 acutely altered the biphasic serum epinephrine release and decreased norepinephrine serum levels in response to RS. Finally, 28-day of 40 µg/day TLQP-21 treatment increased CSS-induced social avoidance of an unfamiliar conspecific. Overall these data support a role for TLQP-21 in stress responses providing a promising starting point to further elucidate its role as a player in stress-related human pathologies.


Asunto(s)
Hipotálamo/metabolismo , Neuropéptidos/metabolismo , Fragmentos de Péptidos/farmacología , Fragmentos de Péptidos/uso terapéutico , Estrés Psicológico/tratamiento farmacológico , Estrés Psicológico/metabolismo , Animales , Reacción de Prevención/efectos de los fármacos , Catecolaminas/sangre , Modelos Animales de Enfermedad , Hipotálamo/efectos de los fármacos , Infusiones Subcutáneas , Inyecciones Intraventriculares , Masculino , Ratones , Ratones Endogámicos ICR , Actividad Motora/efectos de los fármacos , Factores de Crecimiento Nervioso , Fragmentos de Péptidos/administración & dosificación , Conducta Social , Estrés Psicológico/sangre
3.
Mol Psychiatry ; 15(1): 38-52, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18607376

RESUMEN

Autism is a severe developmental disorder, whose pathogenetic underpinnings are still largely unknown. Temporocortical gray matter from six matched patient-control pairs was used to perform post-mortem biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier (AGC), which participates in the aspartate/malate reduced nicotinamide adenine dinucleotide shuttle and is physiologically activated by calcium (Ca(2+)). AGC transport rates were significantly higher in tissue homogenates from all six patients, including those with no history of seizures and with normal electroencephalograms prior to death. This increase was consistently blunted by the Ca(2+) chelator ethylene glycol tetraacetic acid; neocortical Ca(2+) levels were significantly higher in all six patients; no difference in AGC transport rates was found in isolated mitochondria from patients and controls following removal of the Ca(2+)-containing postmitochondrial supernatant. Expression of AGC1, the predominant AGC isoform in brain, and cytochrome c oxidase activity were both increased in autistic patients, indicating an activation of mitochondrial metabolism. Furthermore, oxidized mitochondrial proteins were markedly increased in four of the six patients. Variants of the AGC1-encoding SLC25A12 gene were neither correlated with AGC activation nor associated with autism-spectrum disorders in 309 simplex and 17 multiplex families, whereas some unaffected siblings may carry a protective gene variant. Therefore, excessive Ca(2+) levels are responsible for boosting AGC activity, mitochondrial metabolism and, to a more variable degree, oxidative stress in autistic brains. AGC and altered Ca(2+) homeostasis play a key interactive role in the cascade of signaling events leading to autism: their modulation could provide new preventive and therapeutic strategies.


Asunto(s)
Agrecanos/metabolismo , Calcio/metabolismo , Trastornos Generalizados del Desarrollo Infantil/genética , Trastornos Generalizados del Desarrollo Infantil/metabolismo , Homeostasis/fisiología , Adolescente , Agrecanos/genética , Ácido Aspártico/metabolismo , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Estudios de Casos y Controles , Quelantes/farmacología , Niño , Trastornos Generalizados del Desarrollo Infantil/patología , Preescolar , Ácido Egtácico/farmacología , Complejo IV de Transporte de Electrones/metabolismo , Salud de la Familia , Femenino , Regulación de la Expresión Génica/fisiología , Genotipo , Ácido Glutámico/metabolismo , Homeostasis/efectos de los fármacos , Humanos , Desequilibrio de Ligamiento , Masculino , Mitocondrias/metabolismo , Neocórtex/metabolismo , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/fisiología , Serotonina/sangre , Adulto Joven
4.
Mol Psychiatry ; 14(7): 705-18, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18317465

RESUMEN

Protein kinase C enzymes play an important role in signal transduction, regulation of gene expression and control of cell division and differentiation. The fsI and betaII isoenzymes result from the alternative splicing of the PKCbeta gene (PRKCB1), previously found to be associated with autism. We performed a family-based association study in 229 simplex and 5 multiplex families, and a postmortem study of PRKCB1 gene expression in temporocortical gray matter (BA41/42) of 11 autistic patients and controls. PRKCB1 gene haplotypes are significantly associated with autism (P<0.05) and have the autistic endophenotype of enhanced oligopeptiduria (P<0.05). Temporocortical PRKCB1 gene expression was reduced on average by 35 and 31% for the PRKCB1-1 and PRKCB1-2 isoforms (P<0.01 and <0.05, respectively) according to qPCR. Protein amounts measured for the PKCbetaII isoform were similarly decreased by 35% (P=0.05). Decreased gene expression characterized patients carrying the 'normal' PRKCB1 alleles, whereas patients homozygous for the autism-associated alleles displayed mRNA levels comparable to those of controls. Whole genome expression analysis unveiled a partial disruption in the coordinated expression of PKCbeta-driven genes, including several cytokines. These results confirm the association between autism and PRKCB1 gene variants, point toward PKCbeta roles in altered epithelial permeability, demonstrate a significant downregulation of brain PRKCB1 gene expression in autism and suggest that it could represent a compensatory adjustment aimed at limiting an ongoing dysreactive immune process. Altogether, these data underscore potential PKCbeta roles in autism pathogenesis and spur interest in the identification and functional characterization of PRKCB1 gene variants conferring autism vulnerability.


Asunto(s)
Trastorno Autístico/genética , Trastorno Autístico/patología , Expresión Génica/genética , Predisposición Genética a la Enfermedad , Neocórtex/metabolismo , Proteína Quinasa C/genética , Adolescente , Adulto , Distribución de Chi-Cuadrado , Niño , Preescolar , Salud de la Familia , Femenino , Frecuencia de los Genes , Estudio de Asociación del Genoma Completo/métodos , Genotipo , Humanos , Masculino , Polimorfismo de Nucleótido Simple/genética , Proteína Quinasa C beta , Adulto Joven
5.
Proc Natl Acad Sci U S A ; 103(39): 14584-9, 2006 Sep 26.
Artículo en Inglés | MEDLINE | ID: mdl-16983076

RESUMEN

The vgf gene has been identified as an energy homeostasis regulator. Vgf encodes a 617-aa precursor protein that is processed to yield an incompletely characterized panel of neuropeptides. Until now, it was an unproved assumption that VGF-derived peptides could regulate metabolism. Here, a VGF peptide designated TLQP-21 was identified in rat brain extracts by means of immunoprecipitation, microcapillary liquid chromatography-tandem MS, and database searching algorithms. Chronic intracerebroventricular (i.c.v.) injection of TLQP-21 (15 mug/day for 14 days) increased resting energy expenditure (EE) and rectal temperature in mice. These effects were paralleled by increased epinephrine and up-regulation of brown adipose tissue beta2-AR (beta2 adrenergic receptor) and white adipose tissue (WAT) PPAR-delta (peroxisome proliferator-activated receptor delta), beta3-AR, and UCP1 (uncoupling protein 1) mRNAs and were independent of locomotor activity and thyroid hormones. Hypothalamic gene expression of orexigenic and anorexigenic neuropeptides was unchanged. Furthermore, in mice that were fed a high-fat diet for 14 days, TLQP-21 prevented the increase in body and WAT weight as well as hormonal changes that are associated with a high-fat regimen. Biochemical and molecular analyses suggest that TLQP-21 exerts its effects by stimulating autonomic activation of adrenal medulla and adipose tissues. In conclusion, we present here the identification in the CNS of a previously uncharacterized VGF-derived peptide and prove that its chronic i.c.v. infusion effected an increase in EE and limited the early phase of diet-induced obesity.


Asunto(s)
Dieta/efectos adversos , Metabolismo Energético , Neuropéptidos/metabolismo , Obesidad/inducido químicamente , Péptidos/metabolismo , Tejido Adiposo Pardo/metabolismo , Animales , Glucemia , Ghrelina , Prueba de Tolerancia a la Glucosa , Canales Iónicos/genética , Leptina/sangre , Masculino , Ratones , Proteínas Mitocondriales/genética , Factores de Crecimiento Nervioso , Neuropéptidos/química , PPAR gamma/genética , Hormonas Peptídicas/sangre , Péptidos/química , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Receptores Adrenérgicos beta/genética , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Triglicéridos/sangre , Proteína Desacopladora 1 , Regulación hacia Arriba/genética
6.
Mol Psychiatry ; 10(11): 1006-16, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16027737

RESUMEN

Organophosphates (OPs) are routinely used as pesticides in agriculture and as insecticides within the household. Our prior work on Reelin and APOE delineated a gene-environment interactive model of autism pathogenesis, whereby genetically vulnerable individuals prenatally exposed to OPs during critical periods in neurodevelopment could undergo altered neuronal migration, resulting in an autistic syndrome. Since household use of OPs is far greater in the USA than in Italy, this model was predicted to hold validity in North America, but not in Europe. Here, we indirectly test this hypothesis by assessing linkage/association between autism and variants of the paraoxonase gene (PON1) encoding paraoxonase, the enzyme responsible for OP detoxification. Three functional single nucleotide polymorphisms, PON1 C-108T, L55M, and Q192R, were assessed in 177 Italian and 107 Caucasian-American complete trios with primary autistic probands. As predicted, Caucasian-American and not Italian families display a significant association between autism and PON1 variants less active in vitro on the OP diazinon (R192), according to case-control contrasts (Q192R: chi2=6.33, 1 df, P<0.025), transmission/disequilibrium tests (Q192R: TDT chi2=5.26, 1 df, P<0.025), family-based association tests (Q192R and L55M: FBAT Z=2.291 and 2.435 respectively, P<0.025), and haplotype-based association tests (L55/R192: HBAT Z=2.430, P<0.025). These results are consistent with our model and provide further support for the hypothesis that concurrent genetic vulnerability and environmental OP exposure may possibly contribute to autism pathogenesis in a sizable subgroup of North American individuals.


Asunto(s)
Arildialquilfosfatasa/genética , Trastorno Autístico/enzimología , Trastorno Autístico/genética , Arildialquilfosfatasa/metabolismo , Trastorno Autístico/etiología , Secuencia de Bases , Estudios de Casos y Controles , Niño , ADN/genética , Análisis Mutacional de ADN , Ambiente , Femenino , Variación Genética , Humanos , Insecticidas/metabolismo , Italia , Desequilibrio de Ligamiento , Masculino , Modelos Biológicos , Organofosfatos/metabolismo , Péptidos/orina , Polimorfismo de Nucleótido Simple , Proteína Reelina , Serotonina/sangre , Estados Unidos
7.
Behav Pharmacol ; 15(5-6): 433-42, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15343070

RESUMEN

Fragile X syndrome is an X-linked form of mental retardation including, among others, symptoms such as stereotypic behaviour, hyperactivity, hyperarousal, and cognitive deficits. We hypothesized that hyperactivity and/or compromised attentional, cognitive functions may lead to impaired performance in cognitive tasks in Fmr1 knockout mice, the most widely used animal model of fragile X syndrome, and suggested that psychostimulant treatment may improve performance by acting on one or both components. Since hyperactivity and cognitive functions have been suggested to depend on striatal and prefrontal cortex dopaminergic dysfunction, we assessed whether amphetamine produced beneficial, positive effects by acting on dopaminergic corticostriatal systems. Our results show that Fmr1 knockout mice are not able to discriminate between a familiar object and a novel one in the object recognition test, thus showing a clear-cut cognitive impairment that, to date, has been difficult to demonstrate in other cognitive tasks. Amphetamine improved performance of Fmr1 knockout mice, leading to enhanced ability to discriminate novel versus familiar objects, without significantly affecting locomotor activity. In agreement with behavioural data, amphetamine produced a greater increase in dopamine release in the prefrontal cortex of Fmr1 knockout compared with the wild-type mice, while a weak striatal dopaminergic response was observed in Fmr1 knockout mice. Our data support the view that the psychostimulant ameliorates performance in Fmr1 knockout mice by improving merely cognitive functions through its action on prefrontal cortical dopamine, irrespective of its action on motor hyperactivity. These results indicate that prefrontal cortical dopamine plays a major role in cognitive impairments characterizing Fmr1 knockout mice, thus pointing to an important aetiological factor in the fragile X syndrome.


Asunto(s)
Anfetamina/farmacología , Estimulantes del Sistema Nervioso Central/farmacología , Dopamina/farmacología , Síndrome del Cromosoma X Frágil/fisiopatología , Proteínas del Tejido Nervioso/genética , Corteza Prefrontal/fisiología , Proteínas de Unión al ARN/genética , Reconocimiento en Psicología/efectos de los fármacos , Animales , Trastornos del Conocimiento/genética , Aprendizaje Discriminativo , Dopamina/metabolismo , Proteína de la Discapacidad Intelectual del Síndrome del Cromosoma X Frágil , Síndrome del Cromosoma X Frágil/genética , Discapacidad Intelectual , Masculino , Ratones , Ratones Noqueados
8.
Psychiatr Genet ; 14(2): 73-82, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15167692

RESUMEN

We have previously described linkage/association between reelin gene polymorphisms and autistic disorder. APOE also participates in the Reelin signaling pathway, by competitively antagonizing Reelin binding to APOE receptor 2 and to very-low-density lipoprotein receptors. The APOE2 protein variant displays the lowest receptor binding affinity compared with APOE3 and APOE4. In this study, we assess linkage/association between primary autism and APOE alleles in 223 complete trios, from 119 simplex Italian families and 44 simplex and 29 multiplex Caucasian-American families. Statistically significant disequilibrium favors the transmission of epsilon2 alleles to autistic offspring, over epsilon3 and epsilon4 (allele-wise transmission/disequilibrium test [TDT], chi2 = 6.16, 2 degrees of freedom [d.f.], P<0.05; genotype-wise TDT, chi2 = 10.68, 3 d.f., P<0.05). A novel epsilon3r allele was also discovered in an autistic child and his mother. Autistic patients do not differ significantly from unaffected siblings (allele-wise TDT comparing autistic patients versus unaffected sibs, chi2 = 1.83, 2 d.f., P<0.40, not significant). The major limitation of this study consists of our small sample size of trios including one unaffected sibling, currently not possessing the statistical power necessary to conclusively discriminate a specific association of epsilon2 with autism, from a distorted segregation pattern characterized by enhanced epsilon2 transmission rates both to affected and unaffected offspring. Our findings are thus compatible with either (a) pathogenetic contributions by epsilon2 alleles to autism spectrum vulnerability, requiring additional environmental and/or genetic factors to yield an autistic syndrome, and/or (b) a protective effect of epsilon2 alleles against the enhanced risk of miscarriage and infertility previously described among parents of autistic children.


Asunto(s)
Apolipoproteínas E/genética , Trastorno Autístico/genética , Apolipoproteína E2 , Apolipoproteína E3 , Apolipoproteína E4 , Secuencia de Bases , Cartilla de ADN , Familia , Genotipo , Humanos , Desequilibrio de Ligamiento , Proteína Reelina , Población Blanca
9.
Mol Psychiatry ; 7(7): 795-800, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12192626

RESUMEN

Autism is a biologically-heterogeneous disease. Distinct subgroups of autistic patients may be marked by intermediate phenotypes, such as elevated serotonin (5-HT) blood levels, potentially associated with different underlying disease mechanisms. This could lead to inconsistent genetic association results, such as those of prior studies on serotonin transporter (5-HTT) gene promoter variants and autistic disorder. Contributions of 5-HTT gene promoter alleles to 5-HT blood levels were thus investigated in 134 autistic patients and 291 first-degree relatives. Mean 5-HT blood levels are 11% higher in autistic patients carrying the L/L genotype, compared to patients with the S/S or S/L genotype; this trend is not observed in first-degree relatives. The probability of inheriting L or S alleles is significantly enhanced in patients with 5-HT blood levels above or below the mean, respectively (P < 0.05), but quantitative TDT analyses yield a non-significant trend (P = 0.10), as this polymorphism explains only 2.5% of the variance in 5-HT blood levels of autistic patients. In conclusion, 5-HTT gene promoter variants seemingly exert a small effect on 5-HT blood levels in autistic children, which largely does not account for hyperserotoninemia. Nonetheless, the inconsistent outcome of prior association studies could partly stem from a selection bias of hyper- or hypo-serotoninemic probands.


Asunto(s)
Trastorno Autístico/sangre , Trastorno Autístico/genética , Proteínas Portadoras/genética , Glicoproteínas de Membrana/genética , Proteínas de Transporte de Membrana , Proteínas del Tejido Nervioso , Serotonina/sangre , Niño , Salud de la Familia , Femenino , Variación Genética , Haplotipos , Humanos , Desequilibrio de Ligamiento , Masculino , Regiones Promotoras Genéticas/genética , Proteínas de Transporte de Serotonina en la Membrana Plasmática
10.
Psychiatr Genet ; 11(2): 99-103, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11525425

RESUMEN

Plasmin, a serine protease, is involved in many physiologically relevant processes, including haemostasis, cellular recruitment during immune response, tumour growth, and also neuronal migration and synaptic remodelling. Both tissue-type and urokinase-type plasminogen activators can be efficiently inhibited by plasminogen activator inhibitor-1 (PAI-1), a protease inhibitor of the serpin family. The human PAI-1 gene is located on chromosome 7q, within or close to a region that has been linked to autism in several linkage studies. Autism seems to be characterized by altered neuronal cytoarchitecture, synaptogenesis and possibly also cellular immune responses. We began addressing the potential involvement of the PAI-1 gene in autistic disorder with this linkage/association study, assessing transmission patterns of the 4G/5G polymorphism in the PAI-1 gene promoter that was previously shown to significantly affect PAI-1 plasma levels. No linkage/association was found in 167 trios with autistic probands, recruited in Italy and in the USA. We thus found no evidence that this polymorphism, or putative functionally relevant gene variants in linkage disequilibrium with it, confer vulnerability to autistic disorder.


Asunto(s)
Trastorno Autístico/genética , Cromosomas Humanos Par 7/genética , Inhibidor 1 de Activador Plasminogénico/genética , Polimorfismo Genético , Regiones Promotoras Genéticas/genética , Adolescente , Adulto , Trastorno Autístico/epidemiología , Estudios de Casos y Controles , Niño , Preescolar , Mapeo Cromosómico , Femenino , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Italia/epidemiología , Italia/etnología , Masculino , Países Bajos/etnología , Inhibidor 1 de Activador Plasminogénico/sangre , Reacción en Cadena de la Polimerasa , Estados Unidos/epidemiología
11.
J Neurosci ; 21(17): 6862-73, 2001 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-11517274

RESUMEN

Thalamocortical neurons innervating the barrel cortex in neonatal rodents transiently store serotonin (5-HT) in synaptic vesicles by expressing the plasma membrane serotonin transporter (5-HTT) and the vesicular monoamine transporter (VMAT2). 5-HTT knock-out (ko) mice reveal a nearly complete absence of 5-HT in the cerebral cortex by immunohistochemistry, and of barrels, both at P7 and adulthood. Quantitative electron microscopy reveals that 5-HTT ko affects neither the density of synapses nor the length of synaptic contacts in layer IV. VMAT2 ko mice, completely lacking activity-dependent vesicular release of monoamines including 5-HT, also show a complete lack of 5-HT in the cortex but display largely normal barrel fields, despite sometimes markedly reduced postnatal growth. Transient 5-HTT expression is thus required for barrel pattern formation, whereas activity-dependent vesicular 5-HT release is not.


Asunto(s)
Monoaminas Biogénicas/metabolismo , Proteínas de Transporte de Membrana , Proteínas del Tejido Nervioso , Neuronas Aferentes/metabolismo , Neuropéptidos , Transportadores de Anión Orgánico , Corteza Somatosensorial/metabolismo , Vesículas Sinápticas/metabolismo , Tálamo/metabolismo , Envejecimiento/metabolismo , Animales , Proteínas Portadoras/análisis , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Espacio Extracelular/metabolismo , Fenclonina/farmacología , Proteínas Transportadoras de GABA en la Membrana Plasmática , Inmunohistoquímica , Glicoproteínas de Membrana/deficiencia , Glicoproteínas de Membrana/genética , Proteínas de la Membrana/análisis , Proteínas de la Membrana/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Neuronas Aferentes/ultraestructura , Serotonina/análisis , Serotonina/metabolismo , Antagonistas de la Serotonina/farmacología , Proteínas de Transporte de Serotonina en la Membrana Plasmática , Corteza Somatosensorial/citología , Corteza Somatosensorial/efectos de los fármacos , Sinapsis/metabolismo , Sinapsis/ultraestructura , Tálamo/citología , Proteínas de Transporte Vesicular de Aminas Biógenas , Proteínas de Transporte Vesicular de Monoaminas , Vibrisas/inervación , Vibrisas/fisiología
12.
Mol Psychiatry ; 6(2): 150-9, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11317216

RESUMEN

Autistic disorder (MIM 209850) is currently viewed as a neurodevelopmental disease. Reelin plays a pivotal role in the development of laminar structures including the cerebral cortex, hippocampus, cerebellum and of several brainstem nuclei. Neuroanatomical evidence is consistent with Reelin involvement in autistic disorder. In this study, we describe several polymorphisms identified using RNA-SSCP and DNA sequencing. Association and linkage were assessed comparing 95 Italian patients to 186 ethnically-matched controls, and using the transmission/disequilibrium test and haplotype-based haplotype relative risk in 172 complete trios from 165 families collected in Italy and in the USA. Both case-control and family-based analyses yield a significant association between autistic disorder and a polymorphic GGC repeat located immediately 5' of the reelin gene (RELN) ATG initiator codon, as well as with specific haplotypes formed by this polymorphism with two single-base substitutions located in a splice junction in exon 6 and within exon 50. Triplet repeats located in 5' untranslated regions (5'UTRs) are indicative of strong transcriptional regulation. Our findings suggest that longer triplet repeats in the 5'UTR of the RELN gene confer vulnerability to autistic disorder.


Asunto(s)
Trastorno Autístico/epidemiología , Trastorno Autístico/genética , Moléculas de Adhesión Celular Neuronal/genética , Proteínas de la Matriz Extracelular/genética , Adulto , Anciano , Anciano de 80 o más Años , Alelos , Química Encefálica/genética , Estudios de Casos y Controles , Exones , Salud de la Familia , Femenino , Marcadores Genéticos , Predisposición Genética a la Enfermedad , Haplotipos , Humanos , Desequilibrio de Ligamiento , Masculino , Persona de Mediana Edad , Proteínas del Tejido Nervioso , Mutación Puntual , Polimorfismo de Nucleótido Simple , Sitios de Empalme de ARN/genética , Proteína Reelina , Factores de Riesgo , Serina Endopeptidasas , Serotonina/fisiología , Cráneo/anatomía & histología , Repeticiones de Trinucleótidos
13.
Pharmacol Biochem Behav ; 68(1): 115-24, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11274716

RESUMEN

The neurobiological and behavioral facets of adolescence have been poorly investigated in relation to the vulnerability to psychostimulants. Periadolescent (33-43 days) and adult (>70 days) Sprague-Dawley rats underwent a 3-day treatment history with D-amphetamine (AMPH) at 0, 2, or 10 mg/kg (once a day). After a short 5-day-long withdrawal interval, freely moving animals were challenged with a 2-mg/kg AMPH dose and their behavior as well as in vivo intrastriatum dopamine (DA) release in the CNS were assessed. Microdialysis data indicated that AMPH-history periadolescent rats showed a prominent sensitization of AMPH-stimulated DA release, whereas no such change was found in adult subjects. As expected, acute AMPH administration strongly reduced time spent lying still and increased levels of cage exploration in animals of both ages. A treatment history of high AMPH dosage was associated with a marked sensitization of the exploratory behavior in adults, whereas it induced a quite opposite profile in periadolescents. The latter group only was also characterized by a compulsive involvement in the stereotyped head-bobbing response. These results indicate that differently from adults, marked alterations in neurobiological target mechanisms are observed in rats around periadolescence as a consequence of a quite mild regimen of intermittent AMPH exposure. Thus, a neurobiological substrate for an age-related increased vulnerability towards the addictive risks of these drugs is suggested.


Asunto(s)
Envejecimiento/psicología , Conducta Animal/efectos de los fármacos , Dextroanfetamina/farmacología , Inhibidores de Captación de Dopamina/farmacología , Dopamina/fisiología , Neostriado/fisiología , Ácido 3,4-Dihidroxifenilacético/metabolismo , Animales , Peso Corporal/efectos de los fármacos , Química Encefálica/efectos de los fármacos , Núcleo Caudado/fisiología , Cromatografía Líquida de Alta Presión , Relación Dosis-Respuesta a Droga , Conducta Exploratoria/efectos de los fármacos , Femenino , Ácido Homovanílico/metabolismo , Microdiálisis , Neostriado/efectos de los fármacos , Embarazo , Putamen/fisiología , Ratas , Ratas Sprague-Dawley , Conducta Estereotipada/efectos de los fármacos
14.
Am J Med Genet ; 96(6): 784-90, 2000 Dec 04.
Artículo en Inglés | MEDLINE | ID: mdl-11121182

RESUMEN

Adenosine deaminase (ADA) plays a relevant role in purine metabolism, immune responses, and peptidase activity, which may be altered in some autistic patients. Codominant ADA1 and ADA2 alleles code for ADA1 and ADA2 allozymes, the most frequent protein isoforms in the general population. Individuals carrying one copy of the ADA2 allele display 15 to 20% lower catalytic activity compared to ADA1 homozygotes. Recent preliminary data suggest that ADA2 alleles may be more frequent among autistic patients than healthy controls. The present study was undertaken to replicate these findings in a new case-control study, to test for linkage/association using a family-based design, and to characterize ADA2-carrying patients by serotonin blood levels, peptiduria, and head circumference. ADA2 alleles were significantly more frequent in 91 Caucasian autistic patients of Italian descent than in 152 unaffected controls (17.6% vs. 7.9%, P = 0.018), as well as among their fathers. Family-based tests involving these 91 singleton families, as well as 44 additional Caucasian-American trios, did not support significant linkage/association. However, the observed preferential maternal transmission of ADA2 alleles, if replicated, may point toward linkage disequilibrium between the ADA2 polymorphism and an imprinted gene variant located in its vicinity. Racial and ethnic differences in ADA allelic distributions, together with the low frequency of the ADA2 allele, may pose methodological problems to future linkage/association studies. Direct assessments of ADA catalytic activity in autistic individuals and unaffected siblings carrying ADA1/ADA1 vs ADA1/ADA2 genotypes may provide stronger evidence of ADA2 contributions to autistic disorder. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 96:784-790, 2000.


Asunto(s)
Adenosina Desaminasa/genética , Alelos , Trastorno Autístico/genética , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Trastorno Autístico/sangre , Trastorno Autístico/orina , Estudios de Casos y Controles , Cefalometría , Niño , Preescolar , ADN/genética , Salud de la Familia , Femenino , Frecuencia de los Genes , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Péptidos/orina , Serotonina/sangre
15.
Clin Chem Lab Med ; 38(3): 251-60, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10905763

RESUMEN

Thyrotropin (TSH), free thyroxine (fT4) and testosterone assays have been used as a probe to evaluate the performances of a new modular chemiluminescence (CL) immunoassay analyser, the Abbott Architect 2000. The evaluation was run in parallel on other systems that use CL as the detection reaction: DPC Immulite, Chiron Diagnostics ACS-180 and ACS Centaur (TSH functional sensitivity only). TSH functional sensitivity was 0.0012, 0.009, 0.033 and 0.039 mU/I for the Architect, Immulite, ACS Centaur and ACS-180, respectively. Testosterone functional sensitivity was 0.38, 3.7 and 2.0 nmol/l for Architect, Immulite and ACS-180, respectively. Good correlation was obtained between the ACS-180 and Architect for all assays. The Immulite correlation did not agree well with the Architect or ACS-180 for fT4 and testosterone but was in good agreement for TSH. Regarding fT4 and testosterone, equilibrium dialysis and isotopic dilution gas-chromatography mass-spectrometry (GC-MS) respectively were used as reference methods. For both within- and between-run precision, the Architect showed the best reproducibility for all three analytes (CV < 6%).


Asunto(s)
Inmunoensayo/instrumentación , Inmunoensayo/métodos , Mediciones Luminiscentes , Automatización , Calibración , Estudios de Casos y Controles , Femenino , Cromatografía de Gases y Espectrometría de Masas , Humanos , Hipertiroidismo/sangre , Hipotiroidismo/sangre , Fallo Renal Crónico/sangre , Masculino , Embarazo , Reproducibilidad de los Resultados , Factor Reumatoide/sangre , Sensibilidad y Especificidad , Testosterona/sangre , Tirotropina/sangre , Tiroxina/sangre , Factores de Tiempo
16.
Neuroreport ; 11(6): 1361-4, 2000 Apr 27.
Artículo en Inglés | MEDLINE | ID: mdl-10817622

RESUMEN

Clinical data suggest that brain catecholamines and serotonin are deficient in phenylketonuria (PKU), an inherited metabolic disorder that causes severe mental retardation and neurological disturbances. To test this hypothesis, brain tissue levels of dopamine (DA), norepinephrine (NE), 5-hydroxytryptamine (5-HT) and their metabolites were evaluated in the genetic mouse model of PKU (Pah(enu2)). Results indicated a significant reduction of 5-HT levels and metabolism in prefrontal cortex (pFC), cingulate cortex (Cg), nucleus accumbens (NAc), caudate putamen (CP), hippocampus (HIP) and amygdala (AMY). NE content and metabolism were reduced in pFC, Cg, AMY and HIP. Finally, significantly reduced DA content and metabolism was observed in pFC, NAc, CP and AMY. In pFC, NAc and CP there was also a marked reduction of DA release.


Asunto(s)
Monoaminas Biogénicas/deficiencia , Encéfalo/metabolismo , Fenilcetonurias/metabolismo , Ácido 3,4-Dihidroxifenilacético/metabolismo , Amígdala del Cerebelo/metabolismo , Animales , Monoaminas Biogénicas/genética , Monoaminas Biogénicas/metabolismo , Núcleo Caudado/metabolismo , Modelos Animales de Enfermedad , Dopamina/análogos & derivados , Dopamina/metabolismo , Femenino , Giro del Cíngulo/metabolismo , Hipocampo/metabolismo , Ácido Homovanílico/metabolismo , Ácido Hidroxiindolacético/metabolismo , Masculino , Metoxihidroxifenilglicol/metabolismo , Ratones , Ratones Mutantes Neurológicos , Norepinefrina/metabolismo , Núcleo Accumbens/metabolismo , Fenilcetonurias/genética , Corteza Prefrontal/metabolismo , Putamen/metabolismo , Serotonina/metabolismo
17.
Pharmacol Res ; 40(4): 333-8, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10527645

RESUMEN

Acamprosate (calcium acetylhomotaurinate) is a GABA derivative that prevents drinking relapses in a significant number of alcoholics. Since little is known about the interaction of acamprosate with other addictive drugs, we studied the effects of this agent (as sodium salt) in two groups of rats trained to discriminate, respectively, morphine (1.7 mg kg(-1)i.p.) or amphetamine (0.5 mg kg(-1)i.p.) from solvent in a two-lever fixed ratio 30 operant behaviour reinforced by water access. Accordingly to the finding that acamprosate inhibits the action of excitatory aminoacids, its effects were compared with those of dizocilpine (MK-801), an NMDA antagonist. Results show that acamprosate (170 and 320 mg kg(-1)i.p. ) produced a slight, and not significant, shift to the left of generalization curves of both morphine and amphetamine without affecting response rates. In contrast, MK-801 potentiated response rate effects of both morphine and amphetamine without affecting their generalization curves. As far as discriminative stimuli participate in the relapsing process of addiction, our results do not predict a role of acamprosate in the prevention of amphetamine or morphine abuse relapsing.


Asunto(s)
Disuasivos de Alcohol/farmacología , Anfetamina/farmacología , Estimulantes del Sistema Nervioso Central/farmacología , Aprendizaje Discriminativo/efectos de los fármacos , Morfina/farmacología , Narcóticos/farmacología , Taurina/análogos & derivados , Acamprosato , Animales , Maleato de Dizocilpina/farmacología , Quimioterapia Combinada , Antagonistas de Aminoácidos Excitadores/farmacología , Masculino , Ratas , Ratas Sprague-Dawley , Tiempo de Reacción/efectos de los fármacos , Taurina/farmacología
18.
Behav Brain Res ; 92(1): 11-20, 1998 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9588681

RESUMEN

Like psychomotor stimulants, a weak amphetamine-like agent, such as phenylpropanolamine, enhances the analgesic effects of morphine (MOR). Thus, it is possible that full psychomotor stimulant potency is not required to increase the analgesic action of opiates. The validity of this assumption is here tested by studying the ability of (-)-norpseudoephedrine (NPE), an enantiomer of phenylpropanolamine and a metabolite of cathinone, to influence both the analgesic effects of MOR and its discriminative stimulus properties. In mice NPE (5.6-10.0-17.0 mg/kg i.p.) did not prolong the latency to lick or to remove paws from a plate warmed at 54 degrees C. However, it significantly potentiated the analgesic effect of 3.2 mg/kg of MOR. These results were replicated in rats by use of the formalin test, which measures the numbers of hind paw flinches produced by injecting 50 microl of formalin into the dorsal surface of the paw. The higher dose of NPE (17 mg/kg) increased the effect of sub-analgesic doses of MOR (0.56 and 1.0 mg/kg). In rats trained to discriminate between 0.5 mg/kg of amphetamine and solvent in a two-lever operant behavior reinforced by water access. NPE induced a dose-dependent increment of drug lever responding from 0% at 1.0 mg/kg to 100% at 32.0 mg/kg. In contrast, NPE did not generalize for the MOR cue up to the dose of 56.0 mg/kg, which produced a substantial reduction of the response rate. However, when given in combination, NPE attenuated the discriminative effects of MOR and potentiated its inhibitory action on the response rate. These results exclude a direct action of NPE on the mu opiate system. In conclusion, NPE preserves amphetamine-like properties and these properties are probably responsible for the interaction of the drug with the analgesic and discriminative effects of MOR. Therefore, this study contradicts the assumption that the analgesic effects of MOR can be enhanced by a sympathomimetic drug that lacks significant psychostimulant actions.


Asunto(s)
Alcaloides/farmacología , Anfetamina/farmacología , Analgésicos Opioides/antagonistas & inhibidores , Analgésicos Opioides/farmacología , Estimulantes del Sistema Nervioso Central/farmacología , Discriminación en Psicología/efectos de los fármacos , Morfina/antagonistas & inhibidores , Morfina/farmacología , Fenilpropanolamina/farmacología , Animales , Relación Dosis-Respuesta a Droga , Sinergismo Farmacológico , Femenino , Formaldehído , Masculino , Ratones , Dimensión del Dolor/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Tiempo de Reacción/efectos de los fármacos
19.
Dev Biol ; 177(2): 590-8, 1996 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-8806834

RESUMEN

The Drosophila eggshell consists of three major proteinaceous layers: the vitelline membrane, the inner chorionic layer, and the outer endochorion. During the latter stages of oogenesis, the proteins that comprise these layers are synthesized and secreted by epithelial follicle cells which surround the maturing oocyte. While there is considerable knowledge of the structural units which comprise the eggshell layers, there is little knowledge of how individual proteins function or interact with one another to form the structure. Immunoelectron microscopy was used to follow the distribution of four different eggshell proteins in the assembling and mature eggshell. sV23 and sV17, follicle cell proteins synthesized during the early stages of eggshell formation (stages 8-10), were distributed within the vitelline membrane layer at all stages. Despite marked temporal differences in their accumulation profiles, s36 and s18, putative chorion proteins, were similarly distributed throughout the floor, pillars, and roof of the endochorion. Although the vitelline membrane appears to be morphologically complete by stage 11, developmental Western blots and immunolocalization data indicate that molecular dynamism persists within the layer throughout the subsequent choriogenic stages. During early chorion formation the vitelline membrane appears to act as a reservoir for chorion proteins since s36 was found predominantly in the vitelline membrane layer of stage 12 egg chambers. During the late choriogenic stages (13-14), both sV17 and sV23 are processed to smaller derivatives. Interactions between the eggshell layers were suggested by ultrastructural analysis of a sV23 protein null mutant which showed that the structural integrity of the outer chorion is dependent upon the presence of a vitelline membrane component.


Asunto(s)
Corion/metabolismo , Drosophila melanogaster/fisiología , Proteínas del Huevo/metabolismo , Proteínas de la Membrana/metabolismo , Óvulo/crecimiento & desarrollo , Membrana Vitelina/metabolismo , Animales , Antígenos/análisis , Secuencia de Bases , Corion/ultraestructura , Proteínas del Huevo/inmunología , Epítopos/genética , Femenino , Datos de Secuencia Molecular , Oogénesis/fisiología , Óvulo/inmunología , Membrana Vitelina/ultraestructura
20.
Appl Opt ; 31(25): 5211-5, 1992 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-20733695

RESUMEN

Gaussian beam propagation in a gradient-radial-index medium is presented and discussed. A simple geometrical method for modeling the Gaussian beam inside the gradient-index medium has been developed. The results with this method and those predicted by wave optics have been compared in a number of practical cases. Results show the validity of the ray approach. This is also confirmed by experimental tests on a high-power laser-fiber coupler.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...